4th Apr 2016 16:19
| 
 | ||||
| TR-1: NOTIFICATION OF MAJOR INTERESTS IN SHARES | ||||
| 
 | 
 | |||
| 1. Identity of the issuer or the underlying issuerof existing shares to which voting rights areattached: ii | Spire Healthcare Group plc | |||
| 2 Reason for the notification (please tick the appropriate box or boxes): | ||||
| An acquisition or disposal of voting rights | X | |||
| An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached | 
 | |||
| An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments | X | |||
| An event changing the breakdown of voting rights | 
 | |||
| Other (please specify): | 
 | 
 | ||
| 3. Full name of person(s) subject to thenotification obligation: iii | Goldman Sachs Asset Management International | |||
| 4. Full name of shareholder(s) (if different from 3.):iv | Goldman Sachs Asset Management International | |||
| 5. Date of the transaction and date onwhich the threshold is crossed orreached: v | 30 March 2016 | |||
| 6. Date on which issuer notified: | 01 April 2016 | |||
| 7. Threshold(s) that is/are crossed orreached: vi, vii | Below 5% | |||
| 8. Notified details: | ||||||||||||||
| A: Voting rights attached to shares viii, ix | ||||||||||||||
| Class/type ofshares if possible usingthe ISIN CODE | Situation previousto the triggeringtransaction | Resulting situation after the triggering transaction | ||||||||||||
| NumberofShares | NumberofVotingRights | Numberof shares | Number of votingrights | % of voting rights x | ||||||||||
| Direct | Direct xi | Indirect xii | Direct | Indirect | ||||||||||
| 
 
 GB00BNLPYF73 | 7,655,864 | 1.91% | Below 5% | Below 5% | 
 | Below 5% | 
 | |||||||
| 
 | ||||||||||||||
| 
 | ||||||||||||||
| B: Qualifying Financial Instruments | ||||||||||||||
| Resulting situation after the triggering transaction | ||||||||||||||
| Type of financialinstrument | Expirationdate xiii | Exercise/Conversion Period xiv | Number of votingrights that may beacquired if theinstrument isexercised/ converted. | % of votingrights | ||||||||||
| 
 | 
 | 
 | 
 | 
 | ||||||||||
| 
 | ||||||||||||||
| C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi | ||||||||||||||
| Resulting situation after the triggering transaction: | ||||||||||||||
| Type of financialinstrument | Exercise price | Expiration date xvii | Exercise/Conversion period xviii | Number of voting rights instrument refers to 
 | % of voting rights xix, xx 
 | |||||||||
| 
 | Below 5% | Nominal | Delta | |||||||||||
| 
 | Below 5% | |||||||||||||
| 
 | ||||||||||||||
| Total (A+B+C) | ||||||||||||||
| Number of voting rights | Percentage of voting rights | |||||||||||||
| Below 5% | Below 5% | |||||||||||||
| 9. Chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held, if applicable: xxi | ||
| N/A | ||
| 
 | ||
| Proxy Voting: | ||
| 10. Name of the proxy holder: | N/A | |
| 11. Number of voting rights proxy holder will ceaseto hold: | N/A | |
| 12. Date on which proxy holder will cease to holdvoting rights: | N/A | |
| 
 | ||
| 13. Additional information: | Please note, total amount of voting rights have been rounded to 3 decimal places therefore there is a possibility of a rounding error. 
 General email contact: 
 | |
| 14. Contact name: | Joanna Foley | |
| 15. Contact telephone number: | +44 207 051 9996 | |
Related Shares:
Spire Healthcare